Product Detail

Skip to product information
1 of 3

Disclaimer

Research Use Only - Important Disclaimer.

All products listed and sold by Peptides Vela are intended STRICTLY for laboratory research purposes — specifically for in vitro studies. They are NOT INTENDED for human or animal consumption, NOR FOR USE in foods, drugs, cosmetics, medical devices, or diagnostic procedures.

Posologie - IMPORTANT.

The information and materials provided on this website are for educational and informational purposes ONLY.

Listing a product on this website DOES NOT grant a license to use it in any way that may infringe on patents or VIOLATE LAWS.

BPC-157, TB-500 20mg (Blend)

BPC-157, TB-500 20mg (Blend)

Regular price $170.00 USD
Regular price Sale price $170.00 USD
Sale Exhausted
Shipping calculated at checkout.
  • Free Shipping From $150
  • Next Day Shipping
  • Secure Payement & Returns Up To 30 Days
Other Sizes
  • Buy 3 and save 5%
  • Buy 5 and save 7%
  • Buy 10 and save 9%
View full details
Name BPC-157, TB-500 20mg (Blend)
Purity >99%
Molecular Formula Blend
Molecular Weight Blend
Appearance White to off-white lyophilized powder
Storage Conditions 2–8°C, protected from light

BPC-157 and TB-500 (Thymosin Beta-4) are peptides commonly studied for their potential in promoting tissue repair and healing. Both have distinct yet complementary mechanisms that, when combined, may offer synergistic benefits. BPC-157, a stable gastric pentadecapeptide, is derived from a protective protein found in the stomach lining. It has been shown in preclinical studies to accelerate healing of muscles, tendons, and ligaments by promoting angiogenesis (the formation of new blood vessels) and regulating the production of growth factors. Similarly, TB-500, a fragment of the naturally occurring Thymosin Beta-4 protein, plays a key role in cell migration, tissue regeneration, and reducing inflammation.

The potential synergy between these peptides arises from their overlapping yet distinct pathways in tissue repair. While BPC-157 excels at improving blood flow and reducing inflammation, TB-500 focuses on facilitating cellular migration to the injury site and supporting the repair process at the cellular level. Together, they may accelerate healing by addressing multiple aspects of tissue recovery, particularly in sports injuries or chronic conditions where regeneration is compromised. Early animal studies suggest this combination may lead to faster recovery times and improved structural integrity of repaired tissues.

It is crucial to note that while promising, much of the research on BPC-157 and TB-500 remains preclinical.